SCHEMBL4246824

SCHEMBL4246824

C=CCn1c(O[C@@H]2C[C@@H](C(=O)O)N(C(=O)O)C2)nc2ccccc2c1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.44
KMT2A Q03164 6/20 0.44
MEN1 O00255 5/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
RXFP1 Q9HBX9 1/20 0.43
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
HPGD P15428 1/20 0.40
MAPT P10636 2/20 0.39
GAA P10253 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
KDM4E B2RXH2 1/20 0.39
LMNA P02545 2/20 0.38
PLA2G1B P04054 1/20 0.38
ATG4B Q9Y4P1 1/20 0.38
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1260182 0.89 TDP1 (0.44) ALDH1A1KMT2AMEN1CYP1A2CYP3A4
SCHEMBL15093160 0.88 SMN1; SMN2 (0.40) ALDH1A1KMT2AMEN1CYP1A2CYP3A4
SCHEMBL8012771 0.81 P2RX3 (0.45) ALDH1A1KMT2AMEN1CYP1A2CYP3A4
SCHEMBL1073524 0.80 RXFP1 (0.44) ALDH1A1KMT2AMEN1CYP1A2CYP3A4
SCHEMBL15093179 0.78 P2RX3 (0.41) ALDH1A1KMT2AMEN1HPGDMAPT
SCHEMBL12709919 0.77 GAA (0.42) ALDH1A1KMT2AMEN1CYP1A2CYP2C9
SCHEMBL15000107 0.77 RXFP1 (0.38) ALDH1A1KMT2AMEN1CYP1A2CYP3A4
SCHEMBL15000098 0.76 AGTR2 (0.35)
SCHEMBL14999963 0.76 AGTR2 (0.33) ALDH1A1KMT2AMEN1CYP1A2CYP3A4
SCHEMBL1260179 0.75 MEN1 (0.43) ALDH1A1KMT2AMEN1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2271345-B1 HCV NS3 PROTEASE INHIBITORS MERCK SHARP & DOHME (US) 2015-05-20 EP disclosed
US-8461107-B2 HCV NS3 protease inhibitors MERCK SHARP & DOHME CORP. (US) 2013-06-11 US disclosed
WO-2009134624-A1 HCV NS3 PROTEASE INHIBITORS MERCK & CO., INC. (US) 2009-11-05 WO disclosed